Dupilumab Therapy Improves Stratum Corneum Hydration and Skin Dysbiosis in Patients With Atopic Dermatitis
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Purpose: We aimed to investigate the effects of dupilumab on 1) the permeability and antimicrobial barrier, 2) the composition of the skin microbiome, and 3) the correlation between changes in skin barrier properties and microbiota in atopic dermatitis (AD) patients.Methods: Ten patients with severe AD were treated with dupilumab for 12 weeks.Disease severity was assessed using the Eczema Area and Severity Index (EASI).Skin barrier function was evaluated by measuring transepidermal water loss, stratum corneum (SC) hydration, and pH.The following parameters were analyzed in the pre-and post-treatment SC samples; 1) skin microbiota using 16S rRNA gene sequencing, 2) lipid composition using mass spectrometry, and 3) human β-defensin 2 (hBD-2) expression using quantitative reverse transcription polymerase chain reaction.Results: SC hydration levels in the lesional and non-lesional skin increased after 12-week dupilumab therapy (24.2%, P < 0.001 and 59.9%, P < 0.001, respectively, vs. baseline) and correlated with EASI improvement (r = 0.90, P < 0.001 and r = 0.85, P = 0.003, respectively).Dupilumab increased the long-chain ceramide levels in atopic skin (118.4%,P = 0.028 vs. baseline) that correlated with changes in SC hydration (r = 0.81, P = 0.007) and reduced the elevated hBD-2 messenger RNA levels (-15.4%,P = 0.005 vs. baseline) in the lesional skin.Dupilumab decreased the abundance of Staphylococcus aureus.In contrast, the microbial diversity and the abundance of Cutibacterium and Corynebacterium species increased, which were correlated with an increase in SC hydration levels (Shannon diversity, r = 0.71, P = 0.027; Cutibacterium, r = 0.73, P = 0.017; Corynebacterium, r = 0.75, P = 0.012).Increased abundance of Cutibacterium species was also correlated with EASI improvement (r = 0.68, P = 0.032).Conclusions: Th2 blockade-induced normalization of skin microbiome in AD patients is associated with increased SC hydration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grice, E. A., & Segre, J. A. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2537 · Cited by 3,143
Weidinger, S., & Novak, N. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00149-x · Cited by 1,908
Nakatsuji, T., Chen, T. H., Narala, S., Chun, K. A., Two, A. M., Yun, T., Shafiq, F., Kotol, P. F., Bouslimani, A., Melnik, A. V., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah4680 · Cited by 1,095
Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression
Aho, V. T. E., Pereira, P. A. B., Voutilainen, S., Paulin, L., Pekkonen, E., Auvinen, P., & Scheperjans, F. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.05.064 · Cited by 361
Bomar, L., Brugger, S. D., Yost, B. H., Davies, S. S., & Lemon, K. P. (2016) · mBio · doi:10.1128/mbio.01725-15 · Cited by 332
Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice
Kawasaki, H., Nagao, K., Kubo, A., Hata, T., Shimizu, A., Mizuno, H., Yamada, T., & Amagai, M. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.01.068 · Cited by 301
Mechanism of HBD-3 deficiency in atopic dermatitis
Howell, M. D., Boguniewicz, M., Pastore, S., Novak, N., Bieber, T., Girolomoni, G., & Leung, D. Y. M. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.08.008 · Cited by 208
The Role of Th17-Related Cytokines in Atopic Dermatitis
Sugaya, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041314 · Cited by 204
The skin microbiome is different in pediatric versus adult atopic dermatitis
Shi, B., Bangayan, N. J., Curd, E., Taylor, P. A., Gallo, R. L., Leung, D. Y. M., & Li, H. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.04.053 · Cited by 161
Cited by
Recent advancements in the atopic dermatitis mechanism
Savva, M., Papadopoulos, N. G., Gregoriou, S., Katsarou, S., Papapostolou, N., Makris, M., & Xepapadaki, P. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2902084 · Cited by 53
Atopic Dermatitis: The Relationship Between Immune Mediators and Skin Lipid Barrier
You, H., & Liang, Y. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09057-y · Cited by 17
Greenzaid, J. D., Chan, L. J., Chandani, B. M., Kiritsis, N. R., & Feldman, S. R. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2326625 · Cited by 17
“…with AD, dupilumab increased bacterial diversity compared to baseline in both lesional (baseline, 2.9 vs. week 12, 4.4; p = .005) and non-lesional (baseline, 3.34 vs. week 12, 4.6; p = .004) skin; this effectively restored microbial diversity to levels comparable with healthy controls [76].”
BackgroundResultInfluential
Metadata
- Authors
- Lee, S.-J., Kim, S.-E., Shin, K.-O., Park, K., & Lee, S. E.
- Venue
- Allergy, Asthma & Immunology Research
- Publisher
- XMLink
- Published
- 2021
- Volume
- 13
- Issue
- 5
- Pages
- 762
- ISSN
- 2092-7355 (ISSN-L)
- 2092-7363
- OpenAlex
- W3165667037
- Cited by
- 47
- References
- 9
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dupilumab Therapy Improves Stratum Corneum Hydration and Skin Dysbiosis in Patients With Atopic Dermatitis. https://app.cochat.ai/papers/10.4168/aair.2021.13.5.762
- The paper
- Lee, S.-J., Kim, S.-E., Shin, K.-O., Park, K., & Lee, S. E. (2021). Dupilumab Therapy Improves Stratum Corneum Hydration and Skin Dysbiosis in Patients With Atopic Dermatitis. Allergy, Asthma & Immunology Research. https://doi.org/10.4168/aair.2021.13.5.762
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.